Related Experiment Video
Updated: Jul 4, 2026

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
Published on: December 18, 2012
Subconjunctival bevacizumab for corneal neovascularization in herpetic stromal keratitis
1Centrovision Mendoza, National University of Cuyo, Mendoza, Argentina. macarras73@gmail.com
Purpose:
To report an 81-year-old woman with corneal neovascularization secondary to herpetic stromal keratitis treated with subconjunctival bevacizumab and to discuss the role of this novel antiangiogenic treatment.
Methods:
Case report and review of medical literature.
Results:
A dramatic regression of corneal vessels was observed 1 week after the injection. After a 3-month follow-up, there was no recurrence of corneal revascularization.
Conclusions:
Bevacizumab may be a valid complementary treatment in patients with corneal neovascularization caused by herpetic stromal keratitis.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Genital Herpes